DSIP, or delta sleep-inducing peptide, is a naturally occurring neuropeptide first isolated from brain tissue. It is used in neuronal culture models to study NMDA receptor and adrenergic signalling pathways, and NuVion stocks it in Australia as a 10mg lyophilised vial.
- Naturally occurring nine amino acid neuropeptide
- Studied in electrophysiology (EEG) research models
- Applied in NMDA receptor and adrenergic signalling assays
- Supplied lyophilised, purity by RP-HPLC and identity by mass spectrometry
DSIP structure and research use
DSIP is a nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. It was first isolated in the 1970s and has since been detected in several tissues outside the brain. In the laboratory it is used in neuronal and neuroendocrine cell models for work on NMDA receptor and adrenergic signalling.
DSIP research applications
- Whole-cell patch clamp measurement of NMDA receptor currents in primary neurons, run with scrambled-sequence controls
- Calcium imaging in neuronal or neuroendocrine culture using Fura-2 or a genetically encoded indicator
- Hormone secretion assays in pituitary cell culture, with conditioned medium quantified by ELISA or radioimmunoassay
- Structure-activity studies comparing native DSIP, phosphorylated DSIP and scrambled-sequence analogues under identical conditions
DSIP key facts
| Type | Naturally occurring neuropeptide |
|---|---|
| Amino acid count | 9 |
| Sequence | H-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-OH |
| Molecular formula | C35H48N10O15 |
| Molecular weight | 848.8 g/mol |
| CAS number | 62568-57-4 |
| Also known as | Delta sleep-inducing peptide, DSIP |
| Vial size | 10mg, lyophilised |
| Purity | 99.80% by RP-HPLC, Janoshik Analytical |
| Analysed | 24 September 2026 |
Research profile: DSIP: structure, mechanism and research use
Independent test: a sample of this product was analysed by Janoshik Analytical on 24 September 2026, purity 99.80% by RP-HPLC, test number 234333. The full report opens from the lab band on this page.





